-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
ReShape Lifesciences Inc. quarterly/annual Earnings Per Share, Diluted history and change rate from Q2 2020 to Q3 2025.
- ReShape Lifesciences Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2025 was -3.12 USD/shares, a 99.8% increase year-over-year.
- ReShape Lifesciences Inc. Earnings Per Share, Diluted for the twelve months ending September 30, 2025 was 1.65K USD/shares.
- ReShape Lifesciences Inc. annual Earnings Per Share, Diluted for 2024 was -13.8 USD/shares, a 87.5% increase from 2023.
- ReShape Lifesciences Inc. annual Earnings Per Share, Diluted for 2023 was -111 USD/shares, a 1.81% decline from 2022.
- ReShape Lifesciences Inc. annual Earnings Per Share, Diluted for 2022 was -109 USD/shares, a 62.3% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)